On Friday it was announced that Alere CCG (old Biosite group) and CPG (clinic division) were merging, effective in January. All of the new senior management team is from Biosite. Given the problems that Biosite has had with the FDA, and how they handled their customers throughout the recall, could this be a scenario of polishing the silverware on the Titanic? Is RZ gearing up to spin off the ELISA and Multiplexing and fortifying SD?
Changes at Alere and polishing the silverware on the Titanic
Submitted by Anonymous on Mon, 10/12/2012 - 20:07